Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» R&D
R&D
Scott Gottlieb to biopharma: You wanted us to help modernize R&D, now go out and do it
Endpoints
Fri, 03/15/19 - 11:16 am
FDA
R&D
Scott Gottlieb
Servier and Oncodesign announce Parkinson’s R&D tie-up
Pharmaforum
Wed, 03/13/19 - 11:18 pm
Servier
Oncodesign
R&D
Parkinson's Disease
Healthcare Focused Fund to Invest $100 Million in Harvard Drug Development
CP Wire
Wed, 03/13/19 - 10:14 am
Deerfield Management
Harvard
R&D
Trump's White House proposes raft of cuts to science R&D budgets, but FDA scores higher funds
Endpoints
Tue, 03/12/19 - 10:13 am
Donald Trump
FDA
R&D
New insight into how Biogen's Tecfidera works may lead to better MS therapies
Fierce Biotech
Sat, 03/2/19 - 12:49 pm
Biogen
Tecfidera
MS
multiple sclerois
R&D
Ascletis poaches top MSD China executive as its new R&D chief
Fierce Biotech
Sat, 03/2/19 - 12:43 pm
R&D
China
Ascletis Pharmaceuticals
After a Speedy IPO, Equillium Expands Antibody R&D to Renal Disease
Xconomy
Thu, 02/28/19 - 09:17 pm
Equillium
IPOs
R&D
renal disease
Lundbeck joins with Elsevier to help manage R&D data
Pharmaforum
Thu, 02/28/19 - 09:47 am
Lundbeck
R&D
Elsevier
Reaxis
Doubling down on R&D, Daiichi makes executive changes across its U.S. research unit
Fierce Biotech
Fri, 02/22/19 - 11:46 am
R&D
Daiichi Sankyo
Novartis inks 10-target antibody discovery deal with AbCellera
Fierce Biotech
Thu, 02/14/19 - 09:45 am
Novartis
R&D
antibodies
AbCellera
AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D
Endpoints
Thu, 02/14/19 - 09:43 am
AstraZeneca
MedImmune
R&D
restructring
Charles River swoops on early-stage CRO Citoxlab
Fierce Biotech
Wed, 02/13/19 - 11:18 am
Charles River Labs
M&A
Citoxlab
CROs
R&D
Pharma companies clear the R&D decks in Q4
Pharmaforum
Mon, 02/11/19 - 12:20 pm
R&D
GSK
Sanofi
Eli Lilly
Roche
Gilead Sciences
Sanofi Cuts a Whopping 38 R&D Programs to Refocus on Cancer, Immunology, and Rare Diseases
BioSpace
Thu, 02/7/19 - 11:05 am
Sanofi
Rare Diseases
immunology
cancer
R&D
Galapagos continues fibrosis pipeline buildout with Evotec deal
Fierce Biotech
Thu, 02/7/19 - 09:28 am
Galapagos
Evotec
fibrosis
R&D
Amid R&D rejigs, GlaxoSmithKline axes 6 pipeline assets
Fierce Biotech
Wed, 02/6/19 - 09:50 am
GSK
R&D
Pharma is shuffling around jobs, but a skills gap threatens the process
BioPharma Dive
Mon, 02/4/19 - 01:13 pm
pharma industry
layoffs
R&D
Calico brings on Amgen’s translational R&D head to lead early drug development
Fierce Biotech
Thu, 01/31/19 - 11:26 am
Amgen
R&D
Calico Life Sciences
Alphabet
As Pfizer kills failed PhIII programs for Bavencio, where do they go from here in R&D?
Endpoints
Tue, 01/29/19 - 10:02 am
Pfizer
Bavencio
R&D
The antibiotics R&D effort is broken. Here's one market solution that might fix it
Endpoints
Fri, 01/25/19 - 11:51 am
R&D
antibiotics
Pages
« first
‹ previous
…
31
32
33
34
35
36
37
38
39
…
next ›
last »